Perrigo Company plc Income Taxes Receivable
Perrigo Company plc (PRGO) had Income Taxes Receivable of $74.40 million as of 2014-03-29, per its 10-Q filed 2014-05-07.
Discontinued › Balance Sheet › Assets
us-gaap:IncomeTaxReceivable · last filed 2014-05-07
- 2014-03-29: Income Taxes Receivable $74.40M.
- 2013-12-28: Income Taxes Receivable $79.20M.
- 2013-06-29: Income Taxes Receivable $6.10M.
| Period end | Income Taxes Receivable |
|---|---|
| 2014-03-29 | $74.40M 10-Q · filed 2014-05-07 |
| 2013-12-28 | $79.20M 10-Q · filed 2014-02-06 |
| 2013-06-29 | $6.10M 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |